Sonoma Pharmaceuticals, Inc. SEC filings SNOA

Sonoma Pharmaceuticals, Inc. has 977 filings in SEC EDGAR's recent list, going back to Jan 15, 2002. Its latest annual report, Form 10-K, was filed on Jun 16, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on March 31.

Sonoma Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Jul 28, 2026 Sep 16, 2026
DEFA14A Additional proxy material Jul 23, 2026 —
DEFA14A Additional proxy material Jun 24, 2026 —
DEF 14A Proxy statement May 5, 2026 Jun 24, 2026
PRE 14A Preliminary proxy statement Apr 27, 2026 Apr 24, 2026
DEF 14A Proxy statement Jul 11, 2025 Aug 27, 2025
DEFA14A Additional proxy material Aug 15, 2024 —
DEFA14A Additional proxy material Aug 15, 2024 —
DEFA14A Additional proxy material Jul 24, 2024 —
DEF 14A Proxy statement Jul 1, 2024 Aug 14, 2024
PRE 14A Preliminary proxy statement Jun 21, 2024 Aug 14, 2024
DEFA14A Additional proxy material Sep 15, 2023 —
DEF 14A Proxy statement Jul 27, 2023 Sep 14, 2023
DEF 14A Proxy statement Jul 22, 2022 Sep 15, 2022
DEFA14A Additional proxy material Aug 30, 2021 —
DEFA14A Additional proxy material Aug 23, 2021 —
DEFA14A Additional proxy material Aug 16, 2021 —
DEF 14A Proxy statement Jul 29, 2021 Sep 15, 2021
DEF 14A Proxy statement Jul 29, 2020 Sep 18, 2020
DEFA14A Additional proxy material Oct 18, 2019 —
DEFA14A Additional proxy material Oct 9, 2019 —
DEFA14A Additional proxy material Oct 3, 2019 —
DEFA14A Additional proxy material Sep 18, 2019 —
DEF 14A Proxy statement Jul 29, 2019 Sep 17, 2019
DEFA14A Additional proxy material May 31, 2019 —
DEF 14A Proxy statement Apr 22, 2019 May 30, 2019
PRE 14A Preliminary proxy statement Apr 12, 2019 May 14, 2019
DEF 14A Proxy statement Jul 27, 2018 Sep 10, 2018
PRE 14A Preliminary proxy statement Jul 17, 2018 Sep 10, 2018
DEF 14A Proxy statement Jul 27, 2017 Sep 8, 2017
DEF 14A Proxy statement Jul 29, 2016 Sep 2, 2016
DEFA14A Additional proxy material Sep 24, 2015 —
DEFA14A Additional proxy material Sep 14, 2015 —
DEFA14A Additional proxy material Aug 27, 2015 —
DEF 14A Proxy statement Jul 28, 2015 Sep 10, 2015
PRE 14A Preliminary proxy statement Jul 17, 2015 Sep 10, 2015
DEF 14A Proxy statement Jun 8, 2015 Jun 29, 2015
PRE 14A Preliminary proxy statement May 27, 2015 Jun 29, 2015
DEF 14A Proxy statement Nov 7, 2014 Dec 4, 2014
PRE 14A Preliminary proxy statement Oct 27, 2014 Dec 4, 2014
DEF 14A Proxy statement Jul 29, 2014 Sep 10, 2014
DEF 14A Proxy statement Jul 29, 2013 Sep 12, 2013
DEF 14A Proxy statement Feb 5, 2013 Mar 22, 2013
PRE 14A Preliminary proxy statement Jan 25, 2013 Mar 22, 2013
DEF 14A Proxy statement Jul 27, 2012 Sep 11, 2012
DEF 14A Proxy statement Jul 29, 2011 Sep 12, 2011
DEF 14A Proxy statement Jul 29, 2010 Sep 13, 2010
DEF 14A Proxy statement Jul 29, 2009 Sep 10, 2009
DEF 14A Proxy statement Jul 21, 2008 Aug 27, 2008
PRE 14A Preliminary proxy statement Jul 3, 2008 Aug 27, 2008
DEF 14A Proxy statement Aug 17, 2007 Sep 30, 2007

Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SNOA (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Boulder, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1367083
Former names
Oculus Innovative Sciences, Inc. (until Dec 2, 2016)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.